| Property | Value |
|---|
|
?:abstract
|
-
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak is rising globally However, clinically effective antiviral treatments are not established Favipiravir may prevent pneumonia and acute respiratory distress syndrome aggravation We describe SARS-CoV-2-positive patients, two of whom were in a critical condition and one of whom was in a severe condition, who were administered favipiravir for their deteriorating conditions and cured
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:journal
|
-
International_Journal_of_Infectious_Diseases
|
|
?:license
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
is
?:relation_isRelatedTo_publication
of
|
|
|
?:source
|
|
|
?:title
|
-
Case studies of SARS-CoV-2 treated with favipiravir among patients in critical or severe condition. (Special Issue: Coronavirus (COVID-19) collection.)
|
|
?:type
|
|
|
?:who_covidence_id
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}